• Tae Wan Kim
Part of the Retina Atlas book series (RA)


Toxocariasis is a zoonosis caused by Toxocara canis (dog ascarid) or Toxocara cati (cat ascarid) larvae. Humans become infected by ingesting eggs or larvae from contaminated sources (soil, water, and raw food) or via fecal–oral transmission. Ocular toxocariasis, manifesting as ocular granuloma, was first described by Wilder (1950) in patients with endophthalmitis, Coats disease, or pseudoglioma. Six years later, Nichols found second-stage larvae of T. canis in histological sections from 24 of 46 enucleated eyes with suspected retinoblastoma (Nichols 1956). Human toxocariasis comprises two clinical entities: systemic toxocariasis (also termed visceral larva migrans) and ocular toxocariasis (also termed ocular larva migrans).


  1. Ahn SJ, Woo SJ, Hyon JY, et al. Cataract formation associated with ocular toxocariasis. J Cataract Refract Surg. 2013;39:830–5.CrossRefGoogle Scholar
  2. Ahn SJ, Ryoo NK, Woo SJ. Ocular toxocariasis: clinical features, diagnosis, treatment, and prevention. Asia Pac Allergy. 2014a;4:134–41.CrossRefGoogle Scholar
  3. Ahn SJ, Woo SJ, Jin Y, et al. Clinical features and course of ocular toxocariasis in adults. PLoS Negl Trop Dis. 2014b;8:e2938.CrossRefGoogle Scholar
  4. Alabiad CR, Albini TA, Santos CI, et al. Ocular toxocariasis in a seronegative adult. Ophthalmic Surg Lasers Imaging. 2010;2:1–3.Google Scholar
  5. Biglan AW, Glickman LT, Lobes LA Jr. Serum and vitreous Toxocara antibody in nematode endophthalmitis. Am J Ophthalmol. 1979;88:898–901.CrossRefGoogle Scholar
  6. Chieffi PP, Santos SV, Queiroz ML, et al. Human toxocariasis: contribution by Brazilian researchers. Rev Inst Med Trop Sao Paulo. 2009;51:301–8.CrossRefGoogle Scholar
  7. Cortez RT, Ramirez G, Collet L, et al. Ocular parasitic diseases: a review on toxocariasis and diffuse unilateral subacute neuroretinitis. J Pediatr Ophthalmol Strabismus. 2010;28:1–9.Google Scholar
  8. Fan CK, Hung CC, Du WY, et al. Seroepidemiology of Toxocara canis infection among mountain aboriginal schoolchildren living in contaminated districts in eastern Taiwan. Tropical Med Int Health. 2004;9:1312–8.CrossRefGoogle Scholar
  9. Good B, Holland CV, Taylor MR, et al. Ocular toxocariasis in schoolchildren. Clin Infect Dis. 2004;39:173–8.CrossRefGoogle Scholar
  10. Goto H, Mochizuki M, Yamaki K, et al. Epidemiological survey of intraocular inflammation in Japan. Jpn J Ophthalmol. 2007;51:41–4.CrossRefGoogle Scholar
  11. Jin Y, Shen C, Huh S, et al. Serodiagnosis of toxocariasis by ELISA using crude antigen of Toxocara canis larvae. Korean J Parasitol. 2013;51:433–9.CrossRefGoogle Scholar
  12. Maguire AM, Green WR, Michels RG, et al. Recovery of intraocular Toxocara canis by pars plana vitrectomy. Ophthalmology. 1990;97:675–80.CrossRefGoogle Scholar
  13. Mirdha BR, Khokar SK. Ocular toxocariasis in a North Indian population. J Trop Pediatr. 2002;48:328–30.CrossRefGoogle Scholar
  14. Nichols RL. The etiology of visceral larva migrans. I. Diagnostic morphology of infective second-stage Toxocara larvae. J Parasitol. 1956;42(4 Section 1):349–62.CrossRefGoogle Scholar
  15. Olave AM, Mesa JA, Botero JH, et al. Production and evaluation of the recombinant antigen TES-30 of Toxocara canis for the immunodiagnosis of toxocariasis. Biomedica. 2016;36:39–51.PubMedGoogle Scholar
  16. Park SP, Park I, Park HY, et al. Five cases of ocular toxocariasis confirmed by serology. Korean J Parasitol. 2000;38:267–73.CrossRefGoogle Scholar
  17. Paul M, Stefaniak J, Twardosz-Pawlik H, et al. The co-occurrence of Toxocara ocular and visceral larva migrans syndrome: a case series. Cases J. 2009;2:6881.CrossRefGoogle Scholar
  18. Rolda’n WH, Cavero YA, Espinoza YA, et al. Human toxocariasis: a seroepidemiological survey in the Amazonian city of Yurimaguas, Peru. Rev Inst Med Trop Sao Paulo. 2010;52:37–42.CrossRefGoogle Scholar
  19. Rubinsky-Elefant G, Hirata CE, Yamamoto JH, et al. Human toxocariasis: diagnosis, worldwide seroprevalences and clinical expression of the systemic and ocular forms. Ann Trop Med Parasitol. 2010;104:3–23.CrossRefGoogle Scholar
  20. Sharkey JA, McKay PS. Ocular toxocariasis in a patient with repeatedly negative ELISA titre to Toxocara canis. Br J Ophthalmol. 1993;77:253–4.CrossRefGoogle Scholar
  21. Shields JA. Ocular toxocariasis: a review. Surv Ophthalmol. 1984;28:361–81.CrossRefGoogle Scholar
  22. Sivaratnam D, Subrayan V, Ali NA. Transvitreal migration of a Toxocara larva resulting in a second chorioretinal granuloma. Jpn J Ophthalmol. 2008;52:416–7.CrossRefGoogle Scholar
  23. Smith H, Holland C, Taylor M, et al. How common is human toxocariasis? Towards standardizing our knowledge. Trends Parasitol. 2009;25:182–8.CrossRefGoogle Scholar
  24. Stensvold CR, Skov J, Moller LN, et al. Seroprevalence of human toxocariasis in Denmark. Clin Vaccine Immunol. 2009;16:1372–3.CrossRefGoogle Scholar
  25. Stewart JM, Cubillan LD, Cunningham ET Jr. Prevalence, clinical features, and causes of vision loss among patients with ocular toxocariasis. Retina. 2005;25:1005–13.CrossRefGoogle Scholar
  26. Suzuki T, Joko T, Akao N, et al. Following the migration of a Toxocara larva in the retina by optical coherence tomography and fluorescein angiography. Jpn J Ophthalmol. 2005;49:159–61.CrossRefGoogle Scholar
  27. Van De N, Trung NV, Duyet le V, et al. Molecular diagnosis of an ocular toxocariasis patient in Vietnam. Korean J Parasitol. 2013;51:563–7.CrossRefGoogle Scholar
  28. de Visser L, Rothova A, de Boer JH, et al. Diagnosis of ocular toxocariasis by establishing intraocular antibody production. Am J Ophthalmol. 2008;145:369–74.CrossRefGoogle Scholar
  29. Wilder HC. Nematode endophthalmitis. Trans Am Acad Ophthalmol Otolaryngol. 1950;55:99–109.PubMedGoogle Scholar
  30. Woodhall D, Starr MC, Montgomery SP, Jones JL, Lum F, Read RW, et al. Ocular toxocariasis: epidemiologic, anatomic, and therapeutic variations based on a survey of ophthalmic subspecialists. Ophthalmology. 2012;119:1211–7.CrossRefGoogle Scholar
  31. Yokoi K, Goto H, Sakai J, et al. Clinical features of ocular toxocariasis in Japan. Ocul Immunol Inflamm. 2003;11:269–75.CrossRefGoogle Scholar
  32. Yoon DY, Woo SJ. Intravitreal administration of ranibizumab and bevacizumab for choroidal neovascularization secondary to ocular toxocariasis: a case report. Ocul Immunol Inflamm. 2018;26(4):639–41.PubMedGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  • Tae Wan Kim
    • 1
  1. 1.Department of OphthalmologySeoul National UniversitySeoulSouth Korea

Personalised recommendations